Skip to content

Clinical trials

Completed Waldenstrom Macroglobulinemia trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Waldenstrom Macroglobulinemia Status: Completed Country / region: United Kingdom Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20111
20132
20141
20163
20171
20192

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Cancer Research UK2
University College, London2
ADC Therapeutics S.A.1
BeiGene1
European Organisation for Research and Treatment of Cancer - EORTC1
Gilead Sciences1
Jonsson Comprehensive Cancer Center1
Loxo Oncology, Inc.1
Pharmacyclics LLC.1
Taunton and Somerset Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Waldenstrom Macroglobulinemia13
Lymphoma, Non-Hodgkin6
Leukemia, Lymphocytic, Chronic, B-Cell5
Lymphoma5
Lymphoma, B-Cell, Marginal Zone5
Lymphoma, Follicular5
Lymphoma, B-Cell4
Lymphoma, Mantle-Cell4
Burkitt Lymphoma3
Lymphoma, Large B-Cell, Diffuse3

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.